share_log

HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. 重申买入Cardiol Therapeutics,维持9美元的价格目标
Benzinga ·  06/14 06:05

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

HC Wainwright & Co.分析师Vernon Bernardino重申买进Cardiol Therapeutics(纳斯达克:CRDL)并将目标股价维持在9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发